Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial
Kate M. Bermingham,Inbar Linenberg,Lorenzo Polidori,Francesco Asnicar,Alberto Arrè,Jonathan Wolf,Fatema Badri,Hannah Bernard,Joan Capdevila,William J. Bulsiewicz,Christopher D. Gardner,Jose M. Ordovas,Richard Davies,George Hadjigeorgiou,Wendy L. Hall,Linda M. Delahanty,Ana M. Valdes,Nicola Segata,Tim D. Spector,Sarah E. Berry
DOI: https://doi.org/10.1038/s41591-024-02951-6
IF: 82.9
2024-05-09
Nature Medicine
Abstract:Large variability exists in people's responses to foods. However, the efficacy of personalized dietary advice for health remains understudied. We compared a personalized dietary program (PDP) versus general advice (control) on cardiometabolic health using a randomized clinical trial. The PDP used food characteristics, individual postprandial glucose and triglyceride (TG) responses to foods, microbiomes and health history, to produce personalized food scores in an 18-week app-based program. The control group received standard care dietary advice (US Department of Agriculture Guidelines for Americans, 2020–2025) using online resources, check-ins, video lessons and a leaflet. Primary outcomes were serum low-density lipoprotein cholesterol and TG concentrations at baseline and at 18 weeks. Participants ( n = 347), aged 41–70 years and generally representative of the average US population, were randomized to the PDP ( n = 177) or control ( n = 170). Intention-to-treat analysis ( n = 347) between groups showed significant reduction in TGs (mean difference = −0.13 mmol l −1 ; log-transformed 95% confidence interval = −0.07 to −0.01, P = 0.016). Changes in low-density lipoprotein cholesterol were not significant. There were improvements in secondary outcomes, including body weight, waist circumference, HbA1c, diet quality and microbiome (beta-diversity) ( P < 0.05), particularly in highly adherent PDP participants. However, blood pressure, insulin, glucose, C-peptide, apolipoprotein A1 and B, and postprandial TGs did not differ between groups. No serious intervention-related adverse events were reported. Following a personalized diet led to some improvements in cardiometabolic health compared to standard dietary advice. ClinicalTrials.gov registration: NCT05273268.
biochemistry & molecular biology,cell biology,medicine, research & experimental